StockData
Glucotrack, Inc. logo

Glucotrack, Inc. (GCTK) shareholders

GCTKOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.68−0.04 (-5.56%)

Close on Oct 19, 2026Market cap $3.43MP/E 0.0Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
0.4%
0M of 11M shares
Institutional holders
19
9 new, 3 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Drew Sycoff321,2645.86%13G (passive)Sep 5, 2024
Armistice Capital, LLC
Joint filing with Steven Boyd (9.99%)
101,0759.99%13G (passive)Dec 31, 2025
White Lion Capital LLC79,7349.99%13G (passive)Aug 26, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of GCTKValueChange% of portfolio
Hrt Financial LP13,6960.13%$65.00K+10,9870.00%
Jane Street Group, LLC8,5640.08%$40.98KNew0.00%
Citadel Advisors LLC5,3020.05%$25.37KNew0.00%
Ikarian Capital, LLC3,0550.03%$14.62K–0.00%
Geode Capital Management, LLC2,2800.02%$10.91K−8530.00%
Virtu Financial LLC1,2480.01%$6.00KNew0.00%
Granite Islands Private Wealth, LLC1,0470.01%$5.01KNew0.00%
Boothbay Fund Management, LLC9020.01%$4.31K–0.00%
UBS Group AG8890.01%$4.26K+8420.00%
Citigroup Inc8580.01%$4.11KNew0.00%
Susquehanna International Group, Llp7030.01%$3.36KNew0.00%
Alerus Financial NA2670.00%$1.28K–0.00%
Tower Research Capital LLC (TRC)2290.00%$1.10K–0.00%
Barclays PLC840.00%$402New0.00%
PlanVest Financial, Inc670.00%$319New0.00%
Tradewinds Capital Management, LLC30.00%$16New0.00%
Newbridge Financial Services Group, Inc.20.00%$11–0.00%
SBI Securities Co., Ltd.10.00%$3–0.00%
Osaic Holdings, Inc.00.00%$0–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026190M0.4%9 / 21 / 30M0M
Q1 2026130M0.1%4 / 20 / 10M0M
Q4 2025100M0.0%2 / 23 / 00M0M
Q3 202580M0.0%1 / 22 / 30M0M
Q2 2025100M0.0%10 / 00 / 00M0M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Paul GoodeChief Executive Officer, Director3390.00%Oct 7, 2025
Peter C. WulffChief Financial Officer––Feb 7, 2025
Andrew K. BaloDirector4,6920.04%Oct 7, 2025
Luis MalaveDirector4,0580.04%Oct 7, 2025
Brendel Victoria CarrDirector––Oct 7, 2025
Erin Catherine CarterDirector2,1480.02%Oct 7, 2025
John BallantyneDirector, 10% owner2,747,71725.97%Mar 31, 2025
Robert FischellDirector2,0450.02%Mar 28, 2025
Allen DanzigDirector1,9220.02%Mar 28, 2025
A. Ballantyne Revocable Living Trust dated 08/01/2017 John10% owner2,743,59125.93%Mar 31, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Luis Malave
Director
Oct 3, 2025Award+463––4,058
Andrew K. Balo
Director
Oct 3, 2025Award+1,285––4,692
Erin Catherine Carter
Director
Oct 3, 2025Award+386––2,148
Luis Malave
Director
Jul 11, 2025Award+1,200––3,595
Andrew K. Balo
Director
Jul 11, 2025Award+3,332––3,407
Erin Catherine Carter
Director
Jul 11, 2025Award+1,000––1,762
John Ballantyne
Director, 10% owner
Mar 26, 2025Award+4,126––4,126
Erin Catherine Carter
Director
Mar 26, 2025Award+1,896––45,632
Luis Malave
Director
Mar 26, 2025Award+2,076––143,617
Allen Danzig
Director
Mar 26, 2025Award+1,498––1,922
Andrew K. Balo
Director
Mar 26, 2025Award+4,490––4,490
Robert Fischell
Director
Mar 26, 2025Award+1,498––2,045
Luis Malave
Director
Mar 25, 2025Award+35––2,395
Andrew K. Balo
Director
Mar 25, 2025Award+75––75
Erin Catherine Carter
Director
Mar 25, 2025Award+32––762
Paul Goode
Chief Executive Officer, Director
Mar 25, 2025Other+42––339
John Ballantyne
Director, 10% owner
Mar 12, 2025Option exercise+2,560,553––2,743,591
Erin Catherine Carter
Director
Mar 12, 2025Option exercise+40,297––43,736
A. Ballantyne Revocable Living Trust dated 08/01/2017 John
10% owner
Mar 12, 2025Option exercise+2,560,553––2,743,591
Luis Malave
Director
Mar 12, 2025Option exercise+133,532––141,541
Paul Goode
Chief Executive Officer, Director
Mar 12, 2025Option exercise+15,435––18,989
Paul Goode
Chief Executive Officer, Director
Feb 5, 2025Other+1,500––3,554
John Ballantyne
Director, 10% owner
Nov 14, 2024Other+132,036$31.00$4.09M183,039
Erin Catherine Carter
Director
Nov 14, 2024Conversion+2,078$31.20$64.83K3,439
A. Ballantyne Revocable Living Trust dated 08/01/2017 John
10% owner
Nov 14, 2024Other+132,036$31.00$4.09M183,039
Luis Malave
Director
Nov 14, 2024Conversion+6,886$31.20$214.84K8,009
Paul Goode
Chief Executive Officer, Director
Nov 14, 2024Conversion+796$31.20$24.84K2,054
Drew Sycoff
Director, 10% owner
Apr 22, 2024Buy+182,539.6$1.26$230.00K2,951,258
Erin Catherine Carter
Director
Apr 8, 2024Award+458––1,361
Luis Malave
Director
Apr 8, 2024Award+489––1,123
Allen Danzig
Director
Apr 8, 2024Award+229––424
Robert Fischell
Director
Apr 8, 2024Award+229––547
Erin Catherine Carter
Director
Dec 31, 2023Award+903––903
Luis Malave
Director
Dec 31, 2023Award+362––634
Luis Malave
Director
Apr 20, 2023Award+121––272
Luis Malave
Director
Jan 9, 2023Award+29––151
Luis Malave
Director
Oct 4, 2022Award+44––122
Allen Danzig
Director
Oct 4, 2022Award+44––195
Luis Malave
Director
Jun 30, 2022Award+34––78
Luis Malave
Director
Mar 31, 2022Award+25––44
Luis Malave
Director
Dec 31, 2021Award+11––19
Luis Malave
Director
Sep 30, 2021Award+8––8
Robert Fischell
Director
Aug 24, 2021Award+318––318
Angela Strand Boydston
Director
Mar 20, 2017Award+13,334––13,334
Angela Strand Boydston
Director
Mar 20, 2017Award+4,445––4,445
Leslie Seff
Director
Mar 20, 2017Award+3,334––3,334
Zvi Cohen
Director
Mar 11, 2015Other−120,077––241,625
David Malka
Vice President of Operations, Director
Mar 11, 2015Other−61,471––123,695
Avner Gal
Chairman and CEO, Director
Mar 11, 2015Other−136,162––273,989

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
1M shares short
Days to cover
1.0
At 7M shares a day
Change since last report
+303.6%
From 0M shares
Short volume, 20 days
55.5%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Glucotrack's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,735,514 shares on Sep 25, 2026 over the last 90 days.

See a number that looks wrong?